Chart players

[braden]

ALXA news...
We remind investors that the previous North American deal with Biovail included $40 million upfront. We expect that a new deal for the global rights to AZ-004 will include a similar upfront payment, with potential backend milestones to include approvals in territories outside the U.S. We are optimistic that something gets done around the NDA filing. We would not be surprised to see a deal prior to the actual filing in July 2011 so that Alexza’s partner can be involved in the submission. This is yet another potential major catalyst for the shares in 2011